Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

China flag China · Delayed Price · Currency is CNY
18.46
-0.15 (-0.81%)
Jun 4, 2025, 10:45 AM CST
6.46%
Market Cap 27.73B
Revenue (ttm) 9.42B
Net Income (ttm) 1.15B
Shares Out 1.49B
EPS (ttm) 0.79
PE Ratio 23.57
Forward PE 21.18
Dividend 0.25 (1.45%)
Ex-Dividend Date Jul 10, 2024
Volume 37,576,113
Average Volume 38,073,724
Open 18.38
Previous Close 18.61
Day's Range 18.15 - 18.70
52-Week Range 13.49 - 21.55
Beta 0.38
RSI 77.80
Earnings Date Aug 29, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China. [Read more]

Sector Healthcare
Founded 1989
Employees 9,065
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600521
Full Company Profile

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.

Financial Statements

News

There is no news available yet.